Tonelli M, Wiebe N, Hemmelgarn B, et al
dose-dependent GI adverse events (nausea, vomiting) similar to other amylin analogues Exposure: Dose-proportional increases in Cmax and AUC Gastric Effects: Dose-dependent slowing of gastric emptying confirmed via paracetamol absorption test Appetite Suppression: Reduced ad libitum food intake at doses 1.2 mg Clinical Significance: Established feasibility of once-weekly dosing and identified dose range for Phase 2 studies
Not miracle cures, not internet hacks, but treatments that doctors actually use and that have research behind them
What sets CJC-1295 No DAC apart is its extended half-life compared to the DAC version, allowing for less frequent dosing while maintaining consistent results
Neurological symptoms of vitamin B12 deficiency: analysis of pediatric patients
A human beings defining feature is our brains remarkable abilities